Review
doi: 10.2217/fmb.13.164.
New insights into the interaction of Mycobacterium tuberculosis and human macrophages
Affiliations
- PMID: 24762307
- DOI: 10.2217/fmb.13.164
Item in Clipboard
Review
New insights into the interaction of Mycobacterium tuberculosis and human macrophages
Future Microbiol.
2014.
Abstract
Mycobacterium tuberculosis is a facultative intracellular pathogen. It infects macrophages where it avoids elimination by interfering with host defense mechanisms. Until recently, it was assumed that the acidification of phagosomes is the major strategy of macrophages to eliminate M. tuberculosis. However, there is emerging evidence demonstrating that human macrophages are equipped with additional antimicrobial effector functions. Specifically, autophagy, efferocytosis and antimicrobial peptides have been identified as mechanisms to restrict mycobacterial proliferation. Here we review recent findings on effector functions of human macrophages and mechanisms of the pathogen to interfere with them.
Similar articles
-
Macrophage defense mechanisms against intracellular bacteria.Immunol Rev. 2015 Mar;264(1):182-203. doi: 10.1111/imr.12266. Immunol Rev. 2015. PMID: 25703560 Free PMC article. Review.
-
Human macrophage host defense against Mycobacterium tuberculosis.Curr Opin Immunol. 2008 Aug;20(4):371-6. doi: 10.1016/j.coi.2008.05.014. Epub 2008 Jul 21. Curr Opin Immunol. 2008. PMID: 18602003 Review.
-
Macrophage takeover and the host-bacilli interplay during tuberculosis.Future Microbiol. 2015;10(5):853-72. doi: 10.2217/fmb.15.11. Future Microbiol. 2015. PMID: 26000654 Review.
-
Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin.Cell Host Microbe. 2009 Sep 17;6(3):231-43. doi: 10.1016/j.chom.2009.08.004. Cell Host Microbe. 2009. PMID: 19748465
-
Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis.Immunol Rev. 2015 Mar;264(1):220-32. doi: 10.1111/imr.12268. Immunol Rev. 2015. PMID: 25703562 Review.
Cited by
-
Graphene Oxide-Linezolid Combination as Potential New Anti-Tuberculosis Treatment.Nanomaterials (Basel). 2020 Jul 22;10(8):1431. doi: 10.3390/nano10081431. Nanomaterials (Basel). 2020. PMID: 32707988 Free PMC article.
-
The Role of NRF2 in Mycobacterial Infection.Antioxidants (Basel). 2021 Nov 23;10(12):1861. doi: 10.3390/antiox10121861. Antioxidants (Basel). 2021. PMID: 34942964 Free PMC article. Review.
-
Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.Drug Des Devel Ther. 2015 Aug 7;9:4441-70. doi: 10.2147/DDDT.S79369. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26300629 Free PMC article.
-
The within host dynamics of Mycobacterium avium ssp. paratuberculosis infection in cattle: where time and place matter.Vet Res. 2015 Jun 19;46(1):61. doi: 10.1186/s13567-015-0185-0. Vet Res. 2015. PMID: 26092382 Free PMC article. Review.
-
Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D.Front Immunol. 2019 Nov 5;10:2586. doi: 10.3389/fimmu.2019.02586. eCollection 2019. Front Immunol. 2019. PMID: 31749811 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
